Nectar Lifesciences Limited — Others, 20-01-2025: Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
20-01-2025 | 07:38 pm
20-01-2025 | 07:38 pm
Nectar Lifesciences Ltd. has provided an update on a significant tax relief case, confirming that the Delhi High Court has dismissed the appeal from the Income Tax Department regarding a claim of ₹3.58 Crore. This ruling upholds the earlier decision of the Income Tax Appellant Tribunal, granting tax relief on dividend income from a subsidiary in Sri Lanka. The dismissal of the appeal is a positive outcome for the company, eliminating potential financial burdens from litigation. Investors may view this as a favorable development, reducing uncertainty related to tax liabilities and potentially bolstering positive sentiment towards the company.
No comments yet. Be the first to comment!
